Jeffrey Kunins Sells 9,605 Shares of Axon Enterprise (NASDAQ:AXON) Stock

Axon Enterprise, Inc (NASDAQ:AXON) insider Jeffrey Kunins sold 9,605 shares of Axon Enterprise stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the transaction, the insider directly owned 97,761 shares in the company, valued at $61,266,818.70. This represents a 8.95% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Axon Enterprise Stock Up 2.6%

NASDAQ AXON opened at $613.26 on Wednesday. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $794.29. The company has a market capitalization of $49.82 billion, a P/E ratio of 254.47, a PEG ratio of 9.70 and a beta of 1.39. The company’s 50 day simple moving average is $549.76 and its 200 day simple moving average is $479.31. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The firm had revenue of $904.39 million during the quarter, compared to analysts’ expectations of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm’s revenue for the quarter was up 35.3% compared to the same quarter last year. During the same period last year, the firm posted $2.12 earnings per share. Equities research analysts expect that Axon Enterprise, Inc will post 2.04 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Axon Enterprise

Institutional investors have recently bought and sold shares of the business. Brighton Jones LLC purchased a new stake in shares of Axon Enterprise in the fourth quarter worth approximately $480,000. NewEdge Advisors LLC grew its position in Axon Enterprise by 41.1% during the first quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock valued at $1,207,000 after purchasing an additional 668 shares in the last quarter. Empowered Funds LLC increased its stake in Axon Enterprise by 8.4% in the 1st quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock valued at $1,067,000 after buying an additional 157 shares during the period. Woodline Partners LP increased its stake in Axon Enterprise by 40.6% in the 1st quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock valued at $3,646,000 after buying an additional 2,003 shares during the period. Finally, Sivia Capital Partners LLC purchased a new stake in Axon Enterprise in the 2nd quarter worth approximately $284,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on AXON shares. Piper Sandler raised their price objective on Axon Enterprise from $724.00 to $732.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Needham & Company LLC reaffirmed a “buy” rating on shares of Axon Enterprise in a research report on Thursday, August 6th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $715.00 target price on shares of Axon Enterprise in a report on Thursday, August 6th. Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 10th. Finally, Citizens Jmp reissued a “market outperform” rating and issued a $700.00 price target on shares of Axon Enterprise in a research note on Thursday, June 25th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $730.92.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.